Elite Pharmaceuticals (ELTP) 8-K Amendments to Articles of Incorporation or Bylaws

Exhibit 3.1

Elite Pharmaceuticals, Inc.

NVID: NV20121008448

5. Information being changed:

Section 4.1 of Article IV is amended and, as amended, reads as follows:

“4.1. Authorized Capital Stock. The aggregate number of shares which this Corporation shall have authority to issue is One Billion Four Hundred Forty Five Million Fifteen Thousand (1,445,015,000) shares, consisting of (a) One Billion Four Hundred Forty Five Million (1,445,000,000) shares of Common Stock, par value $0.001 per share (the “Common Stock”), and (b) Fifteen Thousand (15,000) shares of Preferred Stock, par value $0.01 per share (the “Preferred Stock”), issuable in one or more series as hereinafter provided. A description of the classes of shares and a statement of the number of shares in each class and the relative rights, voting power, and preferences granted to and restrictions imposed upon the shares of each class are as follows:”